Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Jumped Today


Shares of Moderna (NASDAQ: MRNA) rose by 6.5% on Thursday after the biotech said it had collected enough data from the phase 3 study of its experimental COVID-19 vaccine to trigger an interim analysis. 

Moderna said enough people in its clinical trial had contracted COVID-19 for the independent Data Safety Monitoring Board (DSMB) to begin a review of the effectiveness of its coronavirus vaccine candidate, mRNA-1273.

Moderna's stock climbed on Thursday as investors looked ahead to a potentially positive outcome for its phase 3 trial of mRNA-1273. Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments